Targeting skin dendritic cells to improve intradermal vaccination.
about
Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell ResponsesMolecular mechanisms for enhanced DNA vaccine immunogenicity.pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.Intradermal grass pollen immunotherapy increases TH2 and IgE responses and worsens respiratory allergic symptoms.Macrophage- and neutrophil-derived TNF-α instructs skin langerhans cells to prime antiviral immune responsesA protective role of murine langerin⁺ cells in immune responses to cutaneous vaccination with microneedle patches.Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein.IL-10 conditioning of human skin affects the distribution of migratory dendritic cell subsets and functional T cell differentiation.Intradermal immunization with wall teichoic acid (WTA) elicits and augments an anti-WTA IgG response that protects mice from methicillin-resistant Staphylococcus aureus infection independent of mannose-binding lectin statusA Comparison of Red Fluorescent Proteins to Model DNA Vaccine Expression by Whole Animal In Vivo Imaging.Animal Models of Rheumatoid Arthritis (I): Pristane-Induced Arthritis in the Rat.Intradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy.Skin dendritic cells induce follicular helper T cells and protective humoral immune responses.Traditional and new influenza vaccinesA HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice.Protocol for a double-blind randomised controlled trial of low dose intradermal grass pollen immunotherapy versus a histamine control on symptoms and medication use in adults with seasonal allergic rhinitis (PollenLITE).Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses.In Vivo Expansion of Melanoma-Specific T Cells Using Microneedle Arrays Coated with Immune-Polyelectrolyte Multilayers.Potent induction of antibody-secreting B cells by human dermal-derived CD14+ dendritic cells triggered by dual TLR ligation.Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.Cytolytic DNA vaccine encoding lytic perforin augments the maturation of- and antigen presentation by- dendritic cells in a time-dependent mannerNear-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine.Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors.E-cadherin interactions are required for Langerhans cell differentiation.Long-lived tissue resident HIV-1 specific memory CD8+ T cells are generated by skin immunization with live virus vectored microneedle arrays.Epicutaneous administration of the pattern recognition receptor agonist polyinosinic-polycytidylic acid activates the MDA5/MAVS pathway in Langerhans cells.Protection against neonatal enteric colibacillosis employing E. Coli-derived outer membrane vesicles in formulation and without vitamin D3.
P2860
Q26777948-EF197125-0D2F-4B1D-BA93-4ADEF1F2F7BFQ30366743-AD1190A7-1928-4169-94F2-EE160E7E1B99Q33703757-8B516DF1-E6C4-4586-B413-BD713166B0C1Q33758296-FDE1F124-6AB6-4891-8A2C-69027C359D15Q34053805-62C0684D-09DC-4F0C-937D-DAA49576DB60Q34055422-B157166E-D5A6-4B5B-89D2-05DCA77DE78DQ34511631-712F6C64-0351-44B7-9E9D-A1F514839C70Q34854946-1FFE5A4F-A653-47B4-9B74-F696F193EA27Q34924567-11FFF47A-59A4-41CD-8BAF-4EFAF58F1969Q35668694-5A2BFD8D-E1B5-46D5-B4DE-97D1643E1811Q36030332-5DC80A49-51CC-48AD-96DD-791C4B80216BQ36223598-7FCBA27E-4348-481E-A30A-EF241A085AEFQ36264950-DB1FAC3E-85CD-44B0-B796-1DC5136B3459Q37035833-1268716C-E4B1-4815-82CD-CF875231A0BCQ37054470-C4EA395E-C434-421D-B6E7-B41A24B9F73AQ37153212-E6DD7FC6-D4B8-4302-8592-5FE4AEE7B6E1Q37419985-AE6623A1-FEFD-46A3-A09F-E8EC68CFB79DQ37682217-7DDDF898-92D6-4938-87B8-F610F3D26499Q38258468-24EDFDA3-508C-436B-A5D8-3A3FC35CCC5FQ38418305-D4A0CC4E-3210-4148-BE8C-6D80C9A2C016Q38619097-6FC7A7EB-04A5-48BC-9FAD-55C461BF1A35Q40134053-DAAF7A4C-6A7E-4061-8666-593515839F94Q42106951-690FACA3-3540-40AF-973A-3ED9B022B578Q42234383-C3E76633-B2FE-4119-95B1-356EABA19910Q45325894-5A31F742-2090-4B4D-B8A5-5C73A404EAB5Q52728576-A3739FC6-87B6-47D8-A4AE-73C2C852F1E6Q55262720-CAB4D871-5870-45CA-A5B0-85FF78BF501D
P2860
Targeting skin dendritic cells to improve intradermal vaccination.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting skin dendritic cells to improve intradermal vaccination.
@en
Targeting skin dendritic cells to improve intradermal vaccination.
@nl
type
label
Targeting skin dendritic cells to improve intradermal vaccination.
@en
Targeting skin dendritic cells to improve intradermal vaccination.
@nl
prefLabel
Targeting skin dendritic cells to improve intradermal vaccination.
@en
Targeting skin dendritic cells to improve intradermal vaccination.
@nl
P2860
P50
P356
P1476
Targeting skin dendritic cells to improve intradermal vaccination
@en
P2093
P2860
P304
P356
10.1007/82_2010_118
P577
2012-01-01T00:00:00Z